Back to company

DR. ZELIG ApS: Financial statements 2022

CVR: 29421323

DR. ZELIG ApS (CVR 29421323) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -21,807 and a net result of DKK -2,042,628 compared with DKK 35,987,470 the year before. Equity amounted to DKK 43,453,089. The solvency ratio was 100%. The company had 1 employee in the financial year.

Gross Profit
-21,807 kr.
Profit/Loss
-2,042,628 kr.
Equity
43,453,089 kr.
Total Assets
43,453,089 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--22 t.-2 mio.43.5 mio.1
2021-155 t.36 mio.47 mio.1
2020--120 t.-241 t.12.5 mio.1
2019-0-5.5 mio.12.9 mio.1
2018--412 t.-651 t.18.4 mio.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on DR. ZELIG ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

DR. ZELIG ApS: The 2021 annual report is outJun 30, 2022

DR. ZELIG ApS has published its annual report for 2021. Gross profit came to DKK 154,503, and the net result was DKK 35,987,470.

About DR. ZELIG ApS

DR. ZELIG ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Morten Edvard Wulff. The company is owned by Morten Edvard Wulff. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 5,881,022 compared with DKK 7,625,711 the year before. Equity amounted to DKK 55,061,769.